Top in hem/onc: Dietary supplements in adults with cancer, ASCO names 2023-2024 president
Click Here to Manage Email Alerts
Many adults who were diagnosed with cancer said they use dietary supplements because they believe the supplements will help lower their risk for disease recurrence, according to a recent study.
Researchers said the results reflect a need for health care professionals to discuss dietary supplements with their patients. It was the top story in hematology/oncology last week.
In other news, the American Society of Clinical Oncology named melanoma specialist Lynn M. Schuchter, MD, FASCO, as its president for the 2023-2024 term.
Read these and more top stories in hematology/oncology below:
Dietary supplement use common among adults with cancer despite no proven benefit
Use of dietary supplements appeared to be common among adults who had been diagnosed with cancer, many of whom believed the supplements could lower the risk for disease recurrence despite a lack of proven benefit, according to a study in Cancer. Read more.
Melanoma specialist named ASCO’s 2023-2024 president
Schuchter, chief of the division of hematology-oncology at Perelman School of Medicine at University of Pennsylvania, will serve a 1-year term as president-elect beginning in June 2022. She will assume the ASCO presidency in June 2023. Read more.
Belly fat to treat brain cancer? Neurosurgeons test method to bypass blood-brain barrier
Surgeons at Lenox Hill Hospital are recruiting patients for a first-in-human, single arm, open-label phase 1 clinical trial investigating the safety and feasibility of using belly fat to treat recurrent glioblastoma. Read more.
Pancreatic cancer cases rise among younger women, especially those aged 15 to 34 years
Pancreatic cancer incidence increased among both men and women from 2000 to 2018, but researchers reported a greater relative increase among women aged younger than 55 years, according to study results published in JAMA. Read more.
12 important studies you may have missed from ASH Annual Meeting and Exposition
Healio provided comprehensive coverage of this year’s ASH Annual Meeting and Exposition. Here are 12 important studies from the meeting that may be relevant to your practice. Read more.